MedPath

Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer

Completed
Conditions
Cervical Cancer
Registration Number
NCT01854983
Lead Sponsor
Asan Medical Center
Brief Summary

Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence imaging for the screening of cervical cancer

Detailed Description

1. Perform pelvic vaginal exam of the subjective to know symptom, illness history, physical exam and basal state before fluorescence colposcopy.

2. Observe acetowhite epithelium and perform biopsy at suspicious lesion during fluorescence colposcopy.

3. Perform fluorescence colposcopy again after biopsy and confirm extraordinary reaction.

4. After 1\~2weeks follow up the subjective at opd and confirm biopsy result.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
80
Inclusion Criteria
  1. age : 20-65 years
  2. abnormal cervical papanicolaou smear , no other specific cervical disease
  3. subject to colposcopic biopsy or LEEP
  4. signed voluntarily to informed concents with full knowledge after explanation abot objective, method, contents
Exclusion Criteria
  1. pregnant women
  2. porphyria
  3. severe cervical bleeding
  4. genital chlamydia, gonorrhea infection
  5. other drug user with possible interaction (e.g. photosensitizer)
  6. no informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fluorescence colposcopic result2weeks after fluorescence colposcopy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath